Compare stocks

Sonova Holding AG is a Swiss company operating in the healthcare industry, specifically focusing on the development, manufacturing, and distribution of hearing care solutions. Its product portfolio includes hearing aids, cochlear implants, wireless communication devices, and professional audiological care services. Founded in 1947, Sonova is headquartered in Stäfa, Switzerland, and serves a global market with its products available in over 100 countries. The company distinguishes itself through continuous innovation in audiological technology and an integrated approach to hearing healthcare, providing both advanced products and comprehensive support services. Sonova’s strategic positioning is enhanced by its focus on research and development, as well as a robust distribution network that includes a mix of retail and wholesale channels.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.